These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20176600)

  • 1. The human G93A SOD1 phenotype closely resembles sporadic amyotrophic lateral sclerosis.
    Synofzik M; Fernández-Santiago R; Maetzler W; Schöls L; Andersen PM
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):764-7. PubMed ID: 20176600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four familial ALS pedigrees discordant for two SOD1 mutations: are all SOD1 mutations pathogenic?
    Felbecker A; Camu W; Valdmanis PN; Sperfeld AD; Waibel S; Steinbach P; Rouleau GA; Ludolph AC; Andersen PM
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):572-7. PubMed ID: 20460594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.
    Pan L; Yoshii Y; Otomo A; Ogawa H; Iwasaki Y; Shang HF; Hadano S
    PLoS One; 2012; 7(3):e33409. PubMed ID: 22438926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?
    Gamez J; Corbera-Bellalta M; Nogales G; Raguer N; García-Arumí E; Badia-Canto M; Lladó-Carbó E; Alvarez-Sabín J
    J Neurol Sci; 2006 Aug; 247(1):21-8. PubMed ID: 16674979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent G41S mutation in Cu/Zn superoxide dismutase gene (SOD1) causing familial amyotrophic lateral sclerosis in a large Polish family.
    Berdyński M; Kuźma-Kozakiewicz M; Ricci C; Kubiszewska J; Millecamps S; Salachas F; Łusakowska A; Carrera P; Meininger V; Battistini S; Kwieciński H; Zekanowski C
    Amyotroph Lateral Scler; 2012 Jan; 13(1):132-6. PubMed ID: 21877919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
    Oh YK; Shin KS; Yuan J; Kang SJ
    J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis.
    Prell T; Lautenschläger J; Witte OW; Carri MT; Grosskreutz J
    Eur J Neurosci; 2012 Mar; 35(5):652-60. PubMed ID: 22390177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
    Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel missense (C7W) mutation of SOD1 in a large familial amyotrophic lateral sclerosis pedigree.
    Wang Z; Cai W; Cui F; Cai T; Chen Z; Mao F; Teng H; Chen L; Wang J; Sun Z; Huang X; Yu P
    Neurobiol Aging; 2014 Mar; 35(3):725.e11-5. PubMed ID: 24094577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel SOD1 mutation in amyotrophic lateral sclerosis with a distinct clinical phenotype.
    Hu J; Chen K; Ni B; Li L; Chen G; Shi S
    Amyotroph Lateral Scler; 2012 Jan; 13(1):149-54. PubMed ID: 22185396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
    Apolloni S; Fabbrizio P; Parisi C; Amadio S; Volonté C
    Mol Neurobiol; 2016 Jan; 53(1):518-531. PubMed ID: 25482048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS.
    Synofzik M; Ronchi D; Keskin I; Basak AN; Wilhelm C; Gobbi C; Birve A; Biskup S; Zecca C; Fernández-Santiago R; Kaugesaar T; Schöls L; Marklund SL; Andersen PM
    Hum Mol Genet; 2012 Aug; 21(16):3568-74. PubMed ID: 22595972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.